A novel 3D high-content assay identifies compounds that prevent fibroblast invasion into tissue surrogates
- PMID: 26475730
- DOI: 10.1016/j.yexcr.2015.10.003
A novel 3D high-content assay identifies compounds that prevent fibroblast invasion into tissue surrogates
Abstract
Invasion processes underlie or accompany several pathological processes but only a limited number of high-throughput capable phenotypic models exist to test anti-invasive compounds in vitro. We here evaluated 3D co-cultures as a high-content phenotypic screening system for fibrotic invasive processes. 3D multicellular spheroids were used as living tissue surrogates in co-culture with fluorescently labeled lung fibroblasts to monitor invasion processes by automated microscopy. This setup was used to screen a compound library containing 480 known bioactive substances. Identified hits prevented fibroblast invasion and could be subdivided into two hit classes. First, Prostaglandins were shown to prevent fibroblast invasion, most likely mediated by the prostaglandin EP2 receptor and generation of cAMP. Additionally, Rho-associated protein kinase (ROCK) inhibitors prevented fibroblast invasion, possibly by inactivation of myosin II. Importantly, both Prostaglandins and ROCK inhibitors are potential treatment options shown to be effective in in vitro and in vivo models of fibrotic diseases. This validates the presented novel phenotypic screening approach for the evaluation of potential inhibitors and the identification of novel compounds with activity in diseases that are associated with fibroblast invasion.
Keywords: 3D co-culture; Fibroblast invasion; High-content invasion assay; Living tissue surrogate; Prostaglandin; ROCK.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy.Cells. 2021 Nov 16;10(11):3196. doi: 10.3390/cells10113196. Cells. 2021. PMID: 34831419 Free PMC article.
-
3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.PLoS One. 2014 Sep 23;9(9):e108283. doi: 10.1371/journal.pone.0108283. eCollection 2014. PLoS One. 2014. PMID: 25247711 Free PMC article.
-
Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors.J Biotechnol. 2010 Feb 1;145(3):295-303. doi: 10.1016/j.jbiotec.2009.12.003. Epub 2009 Dec 4. J Biotechnol. 2010. PMID: 19963024
-
An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments.BMC Cancer. 2019 May 28;19(1):502. doi: 10.1186/s12885-019-5694-1. BMC Cancer. 2019. PMID: 31138163 Free PMC article.
-
Recent advances in three-dimensional multicellular spheroid culture for biomedical research.Biotechnol J. 2008 Oct;3(9-10):1172-84. doi: 10.1002/biot.200700228. Biotechnol J. 2008. PMID: 18566957 Review.
Cited by
-
High-Content Monitoring of Drug Effects in a 3D Spheroid Model.Front Oncol. 2017 Dec 11;7:293. doi: 10.3389/fonc.2017.00293. eCollection 2017. Front Oncol. 2017. PMID: 29322028 Free PMC article.
-
Low dose photodynamic therapy harmonizes with radiation therapy to induce beneficial effects on pancreatic heterocellular spheroids.Oncotarget. 2019 Apr 5;10(27):2625-2643. doi: 10.18632/oncotarget.26780. eCollection 2019 Apr 5. Oncotarget. 2019. PMID: 31080554 Free PMC article.
-
3D Modeling of Epithelial Tumors-The Synergy between Materials Engineering, 3D Bioprinting, High-Content Imaging, and Nanotechnology.Int J Mol Sci. 2021 Jun 9;22(12):6225. doi: 10.3390/ijms22126225. Int J Mol Sci. 2021. PMID: 34207601 Free PMC article. Review.
-
Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model.Sci Rep. 2021 May 25;11(1):10931. doi: 10.1038/s41598-021-90263-x. Sci Rep. 2021. PMID: 34035369 Free PMC article.
-
The adverse outcome pathway for breast cancer: a knowledge management framework bridging biomedicine and toxicology.Discov Oncol. 2023 Dec 5;14(1):223. doi: 10.1007/s12672-023-00840-x. Discov Oncol. 2023. PMID: 38051394 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical